MTCI Investigator awarded €6 million funding by the EU
MTCI Investigator awarded €6 million funding by the EU to investigate possible treatments for difficult-to-treat types of Breast Cancer.
Professor William Gallagher of University College Dublin has been awarded €6 million by the EU to investigate possible treatments for difficult-to-treat types of breast cancer.
“At present, there is a lack of targeted therapies for two poor-prognosis subtypes of breast cancer namely ‘triple negative’ breast tumors and invasive lobular carcinomas of the breast,” says Professor William Gallagher from the UCD Conway Institute who is leading this research. “Together these subtypes make up almost 25% of all breast cancers.”
“Our research will explore the role of kinases – the key regulators of cell function - in these types of breast cancer in order to develop therapeutic targets that may inhibit the rate of activation of kinases in cancer sufferers.”
